Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BiOmega
- Development stage
- Unknown
- Lead developer
- USANA Health Sciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
BiOmega is a high-potency omega-3 dietary supplement developed and manufactured by USANA Health Sciences. It contains concentrated levels of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) derived from cold-water fish oil, along with supplemental Vitamin D3 (cholecalciferol). The primary mechanism of action involves the incorporation of EPA and DHA into cellular phospholipid bilayers, which modulates membrane fluidity and serves as a competitive substrate for enzymes like cyclooxygenase (COX) and lipoxygenase (LOX), thereby reducing the production of pro-inflammatory eicosanoids. Vitamin D3 acts as a ligand for the Vitamin D receptor (VDR), regulating gene expression related to calcium metabolism and immune function. It is primarily indicated for the support of cardiovascular health, cognitive function, and joint health.
- Brand names
- BiOmega
- Other names
- USANA BiOmega
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PPARA (Peroxisome proliferator-activated receptor alpha)VDR (Vitamin D receptor)PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on BiOmega.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BiOmega.